To gain new insights on the issue of what drives trust in OTC medicines, Nielsen and IMS partnered to conduct surveys of consumers and healthcare providers to understand what leads both groups to trust OTC medicines.
Enclosed are comments on "Guidance for Industry; Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use - Labeling for Products that Contain Acetaminophen."
Presentation by Scott Melville, president and CEO of CHPA regarding using innovative technologies and other conditions of safe use to expand which drug products can be considered nonprescription.
This report will reveal analysis and insight into what factors help stimulate growth in the categories that are driving the independent pharmacy front-end.
